The Chemical Biology of NO that Regulates Oncogenic Signaling and Metabolism: NOS2 and Its Role in Inflammatory

Katrina M Miranda1, Lisa A Ridnour2, Robert Y S Cheng2

  • 1Department of Chemistry, University of Arizona, Tucson, Arizona.

PubMed

Insights

Nitric oxide (NO) and its producing enzyme, nitric oxide synthase 2 (NOS2), play critical roles in cancer and inflammation. NO

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Nitric oxide (NO) and nitric oxide synthase 2 (NOS2) are implicated in inflammation and cancer.
  • NOS2 expression in tumors shows varied correlations with patient prognosis.
  • The biological impact of NO is concentration-dependent, influencing specific cellular pathways.

Purpose of the Study:

  • To review the chemical reactions of NO and related species.
  • To discuss how these reactions relate to oncogenic and immunological signaling in cancer.
  • To elucidate the mechanisms by which NO influences cancer outcomes.

Main Methods:

  • Literature review of NO and NOS2 roles in cancer.
  • Analysis of NO reaction kinetics and biological outcomes.
  • Discussion of oncogenic and immunological pathways modulated by NO.

Main Results:

  • NO concentration critically determines pathway activation and biological outcomes.
  • Specific oncogenic and immunological mechanisms are activated by NO.
  • Reaction kinetics dictate the mechanisms of NO action in cancer.

Conclusions:

  • NO and NOS2 are pivotal in cancer-related inflammation and immune responses.
  • Understanding NO's concentration-dependent chemistry is key to predicting cancer prognosis.
  • NO's dual role in cancer necessitates detailed study of its reaction kinetics and signaling pathways.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K